Chemicals
Do new generations of active pharmaceuticals for human use require an adaption of the environmental risk assessment? - Part II: Case studies
In view of the advanced development of new specific active pharmaceutical ingredients, the question arises as to whether the established standard procedures for the environmental risk assessment in the context of marketing authorization are still sufficient to adequately cover relevant effects on environmental organisms. The focus of this project is on specific test strategies for substances from…weiterlesen